Janus N, Launay-Vacher V, Byloos E, et al. Cancer and renal insufficiency results of the BIRMA study. Br J Cancer. 2010;103(12):1815–21. https://doi.org/10.1038/sj.bjc.6605979.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Launay-Vacher V, Oudard S, Janus N, et al. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer. 2007;110(6):1376–84. https://doi.org/10.1002/cncr.22904.

Article  CAS  PubMed  Google Scholar 

Travassos PNC, de Barros Silva PG, Freitas MO, et al. Risk factors for renal impairment in patients with hematological cancer receiving antineoplastic treatment. Support Care Cancer. 2022;30(9):7271–80. https://doi.org/10.1007/s00520-022-07159-3.

Article  PubMed  Google Scholar 

Mahmoodi BK, Gansevoort RT, Naess IA, et al. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation. 2012;126(16):1964–71. https://doi.org/10.1161/CIRCULATIONAHA.112.113944.

Article  PubMed  PubMed Central  Google Scholar 

Ishigami J, Grams ME, Naik RP, et al. Chronic kidney disease and risk for gastrointestinal bleeding in the community: the atherosclerosis risk in communities (ARIC) study. Clin J Am Soc Nephrol. 2016;11(10):1735–43. https://doi.org/10.2215/CJN.02170216.

Article  PubMed  PubMed Central  Google Scholar 

Zimmer-Rapuch S, Lheureux S, Brocard F, et al. Anticancer drugs management in renal insufficiency patients. Bull Cancer. 2012;99(3):323–31. https://doi.org/10.1684/bdc.2011.1489.

Article  PubMed  Google Scholar 

Janus N, Thariat J, Boulanger H, et al. Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol. 2010;21(7):1395–403. https://doi.org/10.1093/annonc/mdp598.

Article  CAS  PubMed  Google Scholar 

Launay Vacher V, Svetlana K, Deray G. GPR® anticancéreux. 4th ed. Paris: Méditions International; 2010. ISBN: 2848020164.

Google Scholar 

Christiansen CF, Johansen MB, Langeberg WJ, et al. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med. 2011;22(4):399–406. https://doi.org/10.1016/j.ejim.2011.05.005.

Article  PubMed  Google Scholar 

Liborio AB, Abreu KL, Silva GB Jr, et al. Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity. Oncology. 2011;80(3–4):160–6. https://doi.org/10.1159/000329042.

Article  PubMed  Google Scholar 

Aloy B, Janus N, Isnard-Bagnis C, et al. Renal toxicity of anticancer drugs. Nephrol Ther. 2021;17(7):553–63. https://doi.org/10.1016/j.nephro.2021.09.001.

Article  PubMed  Google Scholar 

Cosmai L, Porta C, Foramitti M, et al. Preventive strategies for acute kidney injury in cancer patients. Clin Kidney J. 2021;14(1):70–83. https://doi.org/10.1093/ckj/sfaa127.

Article  CAS  PubMed  Google Scholar 

Samuels J, Ng CS, Nates J, et al. Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer. Support Care Cancer. 2011;19(10):1527–32. https://doi.org/10.1007/s00520-010-0978-7.

Article  PubMed  Google Scholar 

Improving Global outcomes (KDIGO) Acute Kidney Injury Working Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl. 2012;2:1–138. https://doi.org/10.1038/kisup.2012.6.

Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. https://doi.org/10.1159/000180580.

Article  CAS  PubMed  Google Scholar 

Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002.

Article  CAS  PubMed  Google Scholar 

Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.

Article  PubMed  PubMed Central  Google Scholar 

Carrier M, Blais N, Crowther M, et al. Treatment algorithm in cancer-associated thrombosis: updated Canadian expert consensus. Curr Oncol. 2021;28(6):5434–51. https://doi.org/10.3390/curroncol28060453.

Article  PubMed  PubMed Central  Google Scholar 

Izzedine H, Launay Vacher V, Deray G. GPR® antalgiques et anti-inflammatoires. 1st ed. Paris: Méditions International; 2003. ISBN: 2848020164.

Google Scholar 

Launay-Vacher V, Karie S, Fau JB, et al. Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adapted. J Pain. 2005;6(3):137–48. https://doi.org/10.1016/j.jpain.2004.11.009.

Article  PubMed  Google Scholar 

Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60(1):139–76. https://doi.org/10.2165/00003495-200060010-00008.

Article  CAS  PubMed  Google Scholar 

Polat EC, Koc A, Demirkan K. The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit. J Clin Pharm Ther. 2022;47(12):2287–94. https://doi.org/10.1111/jcpt.13811.

Article  PubMed  Google Scholar 

Pehlivanli A, Eyupoglu S, Basgut B, et al. Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study. BMC Nephrol. 2023;24(1):149. https://doi.org/10.1186/s12882-023-03210-5.

Article  PubMed  PubMed Central  Google Scholar 

Hou J, Li JF, Yan XJ, et al. The effect of clinical pharmacist intervention on renal function impairment in patients with antimicrobial-induced acute kidney injury in ICU. Patient Prefer Adherence. 2023;17:711–8. https://doi.org/10.2147/PPA.S397873.

Article  PubMed  PubMed Central  Google Scholar 

Launay-Vacher V, Rey JB, Isnard-Bagnis C, et al. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol. 2008;61(6):903–9. https://doi.org/10.1007/s00280-008-0711-0.

Article  CAS  PubMed  Google Scholar